High sensitivity and accuracy of cardiac biomarkers in early detection of cardiovascular disease, promising characteristics such as specificity, quick outcomes and affordable pricing of cardiac point of care testing is driving the market growth. In addition, technological advancement in development of cardiovascular biomarkers and high prevalence of cardiovascular disease and non-invasive techniques, increase in number of products in pipeline and rising number of product approval are other factors boosting the global cardiac biomarkers market for future growth. However, stringent unmet regulation of government, side effects such as skeletal muscle injury, confirmation in result and complex process restrain the market growth.
The global cardiac biomarker market is categorized on the basis of type of marker, application, location of testing and region. On the basis of type of marker is market is segmented into CREATINE KINASE, Troponins (T, I), Myoglobin, Natriuretic peptides (BNP and NT-proBNP), Ischemia Modified Albumin and others. By application, it is divided into Myocardial Infarction, Acute Coronary Syndrome, Congestive Heart Failure, Atherosclerosis and Others. Considering location of testing the market is classified into point of care testing and laboratory testing. The troponins type of biomarker is expected to grow at highest rate owing to its immense specificity and efficiency to precisely detect the cardiac events of acute coronary syndrome.
Check Discount on this report @ http://bit.ly/2HgE4LR
Based on Geography, the global cardiac biomarkers market is studied across North America, Europe, Asia-Pacific and LAMEA. North America is anticipated to account largest share of the market. Factors attributing to the North America’s growth are increased prevalence of cardiovascular diseases, awareness among population regarding cardiac diagnostic solutions along with high demand for cardiac testing. Followed by North America Asia-Pacific is expected to witness speedy growth in the global cardiac biomarkers market mainly owing to rapidly growing population, modernization and increased affordability for highly advanced cardiac treatments.
The key players actively working in the industry of global cardiac biomarkers are Abbott Laboratories, Roche Diagnostics, Alere Inc., Ortho Clinical Diagnostics, Becton, Dickinson and Co., BioMerieux, Siemens Healthcare, Beckman Coulter and Thermo Fisher Scientific.
About Garner Insights:
Garner Insights (GarnerInsights.com) is a Market Intelligence and Business Consulting firm led by professionals with a vast experience and knowledge of the market research industry.
Our vast repository of research reports across various categories, gives you a complete view of the ever-evolving trends and current topics worldwide. Our constant focus is on improving the data and finding innovative methods, which will help your business drive profitable growth.The research methodology is designed to cater all your research needs which is backed by exclusive quantitative and analytics driven intelligence. It consists of primary and secondary methods which is a testimony of the information comprised. The meticulous and distinct data gathering methods are in line with the highest standards of data mining in the industry.
Mr. Kevin Thomas
+1 513 549 5911 (US)
+44 203 318 2846 (UK)
Email – sales@GarnerInsights.com